Safety and tolerability of NVA237, a once-daily long-acting muscarinic antagonist, in COPD patients

  1. Vogelmeier, C.
  2. Verkindre, C.
  3. Cheung, D.
  4. Galdiz, J.B.
  5. Güçlü, S.Z.
  6. Spangenthal, S.
  7. Overend, T.
  8. Henley, M.
  9. Mizutani, G.
  10. Zeldin, R.K.
Journal:
Pulmonary Pharmacology and Therapeutics

ISSN: 1094-5539,  1522-9629

Year of publication: 2010

Volume: 23

Issue: 5

Pages: 438-444

Type: Article

DOI: 10.1016/J.PUPT.2010.04.005 GOOGLE SCHOLAR

Sustainable development goals

Data source: Scopus